B Zhen - Concepedia

Concepedia

Author

B Zhen

Response Technologies (United States)

Also Known As

B Zhen, B.M. Siwei Zhen, BO ZHEN, Bo Zhen

19

Publications

2.1K

Citations

13

H-Index

29

Concepts

All Affiliations

Response Technologies (United States)

BZ

About

B Zhen is an author at Response Technologies (United States) specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	321
2	Health Sciences	5	5	167
3	Cell Biology	3	3	69
4	Public Health	1	1	58
5	Biomedical Engineering	1	1	60

B Zhen

×

13

Publications

2.1K

Citations

12

H-Index

	Year	Citations
Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak Mengyuan Dai, Dianbo Liu, Miao Liu, Cancer Discovery	2020	1.6K
Effect of CD34<sup>+</sup> Cell Dose on Resource Utilization in Patients After High-Dose Chemotherapy With Peripheral-Blood Stem-Cell Support Kevin A. Schulman, Robert Birch, B Zhen, Journal of Clinical Oncology	1999	79
Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell content CH Weaver, Joseph L. Potz, Janice Redmond, Bone Marrow Transplantation Regenerative MedicineCell TherapyMarrow TransplantationHealth SciencesMedicine	1997	60
Second Attempts at Mobilization of Peripheral Blood Stem Cells in Patients with Initial Low CD34+ Cell Yields Charles H. Weaver, Kurt W. Tauer, B Zhen, Journal of Hematotherapy	1998	59
Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multi-Center Study During the COVID-19 Outbreak Mengyuan Dai, Dianbo Liu, Miao Liu, SSRN Electronic Journal Virus EpidemiologyMedicineCovid-19 PandemicVirologyCovid-19 Outbreak	2020	58
High-dose chemotherapy in patients with breast cancer: evaluation of infusing peripheral blood stem cells containing occult tumor cells CH Weaver, TJ Moss, LS Schwartzberg, Bone Marrow Transplantation Breast OncologyMedicineOccult Tumor CellsBreast CancerHigh-dose Chemotherapy	1998	31
High-dose chemotherapy with BUCY or BEAC and unpurged peripheral blood stem cell infusion in patients with low-grade non-Hodgkin’s lymphoma CH Weaver, L. Schwartzberg, S Rhinehart, Bone Marrow Transplantation Hematological MalignancyLymphoid NeoplasiaCell TherapyMedicineHematology	1998	30
A phase I–II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinoma CH Weaver, FA Greco, J. D. Hainsworth, Bone Marrow Transplantation Breast OncologyMedicineGynecologyBreast CancerBreast Carcinoma	1997	29
High-dose chemotherapy and peripheral blood stem cell infusion in patients with non-Hodgkin’s lymphoma: results of outpatient treatment in community cancer centers CH Weaver, Lee S. Schwartzberg, B Zhen, Bone Marrow Transplantation Hematological MalignancyLymphoid NeoplasiaOncologyHematologyCommunity Cancer Centers	1997	28
Phase I–II evaluation of rapid sequence tandem high-dose melphalan with peripheral blood stem cell support in patients with multiple myeloma CH Weaver, B Zhen, LS Schwartzberg, Bone Marrow Transplantation Hematological MalignancyMedicineHigh-dose MelphalanImmunologyHematology	1998	28

Page 1